The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 07, 2012

Filed:

May. 23, 2006
Applicants:

Matthias Schwarz, Gland (VD), CH;

Eric Sebille, Le Poizat, FR;

Christophe Cleva, La Tour, FR;

Cedric Merlot, Collonges-sous-Saleve, FR;

Dennis Church, Commugny, CH;

Patrick Page, Saint-Julien-en-Genevois, FR;

Jacqueline A. Macritchie, Saffron Walden, GB;

John Frederick Atherall, Saffron Walden, GB;

Stefano Crosignani, St. Genis-Pouilly, FR;

Doris Pupowicz, Veyrier, CH;

Inventors:

Matthias Schwarz, Gland (VD), CH;

Eric Sebille, Le Poizat, FR;

Christophe Cleva, La Tour, FR;

Cedric Merlot, Collonges-sous-Saleve, FR;

Dennis Church, Commugny, CH;

Patrick Page, Saint-Julien-en-Genevois, FR;

Jacqueline A. Macritchie, Saffron Walden, GB;

John Frederick Atherall, Saffron Walden, GB;

Stefano Crosignani, St. Genis-Pouilly, FR;

Doris Pupowicz, Veyrier, CH;

Assignee:

Merck Serono SA, Vaud, CH;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 277/20 (2006.01); C07D 271/06 (2006.01); C07D 417/14 (2006.01); C07D 487/10 (2006.01); C07D 261/06 (2006.01); A61K 31/44 (2006.01); A61K 31/431 (2006.01); A61K 31/4184 (2006.01); A61K 31/4196 (2006.01); A61K 31/41 (2006.01);
U.S. Cl.
CPC ...
Abstract

The present invention is related to the use of spiro derivatives of Formula (I) for the treatment and/or prevention of allergic diseases, inflammatory dermatoses and other diseases with an inflammatory component. Specifically, the present invention is related to the use of spiro derivatives for the modulation of CRTH2 activity.


Find Patent Forward Citations

Loading…